7-Epi-10-oxo-docetaxel (Docetaxel Impurity D)
|
|
- CAS-Nr.
- 162784-72-7
- Englisch Name:
- 7-Epi-10-oxo-docetaxel (Docetaxel Impurity D)
- Synonyma:
- Docetaxel EP Impurity D;Docetaxel imp-D;Docetaxel Impurity D;4-Epi-6-oxodocetaxel;7-Epi-10-O-docetaxel;10-OXO-7-epi-Docetaxel;7-Epi-10-oxo Docetaxel;Docetaxel EP Impurityurtiy D;7-Table-10 Carbonyldocetaxel;10-Deoxy-10-Oxo-7-Epi-Oocetaxel
- CBNumber:
- CB61565131
- Summenformel:
- C43H51NO14
- Molgewicht:
- 805.86
- MOL-Datei:
- 162784-72-7.mol
|
7-Epi-10-oxo-docetaxel (Docetaxel Impurity D) Eigenschaften
- Schmelzpunkt:
- >170°C (dec.)
- Siedepunkt:
- 887.3±65.0 °C(Predicted)
- Dichte
- 1.37±0.1 g/cm3 (20 ºC 760 Torr)
- storage temp.
- Refrigerator
- L?slichkeit
- Chloroform (Slightly), Methanol (Slightly)
- pka
- 11.19±0.46(Predicted)
- Aggregatzustand
- Solid
- Farbe
- Pale Yellow to Light Yellow
Sicherheit
7-Epi-10-oxo-docetaxel (Docetaxel Impurity D) Chemische Eigenschaften,Einsatz,Produktion Methoden
Chemische Eigenschaften
Pale Yellow Solid
Verwenden
Docetaxel injection impurity D
7-Epi-10-oxo-docetaxel (Docetaxel Impurity D) Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
7-Epi-10-oxo-docetaxel (Docetaxel Impurity D) Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 96)Lieferanten
162784-72-7()Verwandte Suche:
- (2b,5b,7a,13a)-4-Acetoxy-13-(((2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl)oxy)-1,7-dihydroxy- 9,10-dioxo-5,20-epoxytax-11-en-2-yl Benzoate
- 7-Epi-10-oxo-docetaxel (Docetaxel Impurity D)
- Docetaxel Impurity D
- 7-Epi-10-oxo Docetaxel
- 10-OXO-7-epi-Docetaxel
- 10-Deoxy-10-Oxo-7-Epi-Oocetaxel
- Docetaxel EP Impurity D/ 4-Epi-6-Oxo Docetaxel (10-Deoxy-10-Oxo-7-epi-Docetaxel)
- Benzenepropanoic acid, β-[[(1,1-dimethylethoxy)carbonyl]amino]-α-hydroxy-, (2aR,4R,4aS,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5,6-dioxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-
- [(1S,2S,3R,4S,7R,9R,10S,15S)-4-acetyloxy-1,9-dihydroxy-15-[(2R,3S)-2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]oxy-10,14,17,17-tetramethyl-11,12-dioxo-6-oxatetracyclo[11.3.1.0^{3,10}.0^{4,7}]heptadec-13-en-2-yl] benzoate
- Docetaxel imp-D
- Docetaxel EP impurity D,10-deoxy-10-oxo-7-epi-docetaxel
- Docetaxel EP Impurityurtiy D
- Docetaxel EP Impurity D (7-epi-10-Oxo-Docetaxel)
- 10-deoxy-10-oxo-7-epi-docetaxel
- Docetaxel Impurity 4(Docetaxel EP Impurity D)
- 7-epi-10-oxo-docetaxel / 4-Epi-6-oxodocetaxel
- 4-Epi-6-oxodocetaxel
- Docetaxel EP Impurity D
- 7-Epi-10-O-docetaxel
- 5β,20-epoxy-1,7α-dihydroxy-9,10-dioxotax-11-ene-2α,4,13α-triyl 4-acetate 2-benzoate 13-[(2R,3S)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-3-phenylpropanoate] (10-deoxy-10-oxo-7-epi-docetaxel),
- 7-Table-10 Carbonyldocetaxel
- 162784-72-7
- C43H51NO14
- Chiral Reagents
- Inhibitors
- Chemical Impurities
- Impurities
- Intermediates & Fine Chemicals
- Pharmaceuticals